their potential as therapeutic
targets for CVD. Special emphasis is placed on miRNAs that regulate T cells
Gareev, I,
Gileva, Y,
Dzidzaria, A,
Beylerli, O,
Pavlov, V,
Agaverdiev, M,
Mazorov, B,
Biganyakov, I,
Vardikyan, A,
Jin, M,
Ahmad, A (2021) to predict the course of the disease, and plan treatment.
Therapy of tumors, especially malignant ones
Gareev, Ilgiz,
Beylerli, Ozal,
Tamrazov, Rasim,
Ilyasova, Tatiana,
Shumadalova, Alina,
Du, Weijie,
Yang, Baofeng (2023) effectively
target various structures within the central nervous system (CNS). MiRNA-based
therapy stands out
therapies, in improving the efficiency of immunotherapeutic tools, and in the personification
, it is necessary to develop an effective
therapy for NF1. The effectiveness of complex
therapy of NF1 with use
Yang, L.,
Luo, W.,
Zhang, Q,
Hong, S.,
Wang, Y.,
Samorodov, A.V.,
Chattipakorn, N.,
Pavlov, V.N.,
Liang, G. (2021) no pharmacological
therapy in clinic. Accumulating evidence has demonstrated that natural compounds from herbs have